Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JULY 28, 2007 FBO #2070
SOURCES SOUGHT

65 -- Monitoring and Central Venous Catheters, Kits ans Supplies

Notice Date
7/26/2007
 
Notice Type
Sources Sought
 
NAICS
339113 — Surgical Appliance and Supplies Manufacturing
 
Contracting Office
Department of the Navy, Bureau of Medicine and Surgery, NMC San Diego, Bldg 1 38400 Bob Wilson Drive, San Diego, CA, 92134-5000, UNITED STATES
 
ZIP Code
00000
 
Solicitation Number
Reference-Number-N002597207SS02
 
Response Due
8/15/2007
 
Archive Date
8/30/2007
 
Description
A.General Information TRICARE Southwest Region, a military integrated delivery network, comprised of Army, Navy, and Air Force medical treatment facilities in California announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Monitoring & Central Venous Catheters, Kits & Supplies with a possible multi-vendor award. The primary objective of this standardization initiative is to achieve a best value determination that represents the clinically preferred product or source at the best possible price. It is also intended that standardized product be obtained through the DoD Prime Vendor Program. The major facilities in the area include but are not limited to Naval Medical Center San Diego; David Grant Medical Center, Travis AFB; Naval Hospital Camp Pendleton; Robert E. Bush Hospital, Twenty-Nine Palms; Weed Army Community Hospital, Ft. Irwin; Naval Hospital Lemoore; 9th Medical Group, Beale AFB; 30th Medical Group, Vandenberg AFB; 61st Medical Squadron, Los Angeles AFB; 95th Medical Group, Edwards AFB. This standardization action is part of the Medical/Surgical Prime Vendor program executed by the Defense Supply Center Philadelphia, Directorate of Medical Materiel. In order to participate, your company must have a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the Prime Vendor of the program. This is pursuant to the DAPA clause by which DAPA holders agree to the Standardization process and to allow Prime Vendors to distribute their items. This is a supplement to the Prime Vendor Program and it is not a contract. For additional information regarding DSCP?s Prime vendor program please access our web site at: https://dmmonline.dscp.dla.mil The Tri-Service Regional Business Office (TRBO) will provide anticipated volume (quantity) based on historical usage/forecasted requirements. The agreement will be for a base period of two (2) years (24 months) from date of award with three (3) 12-month option periods. Anticipated award date is January 2008. The evaluation will be based on technical, clinical and pricing factors. The award will be determined utilizing best value/ trade off criteria. Point of Contact: Cindy Ingrao, RN, MSN at (619) 532-8517; Email- cynthia.ingrao@med.navy.mil B.Products & Performance Required The Southwest Region is seeking product line items in the category of Monitoring & Central Venous Catheters, Kits & Supplies comprised of monitoring catheters and their insertion and change kits and supplies for use in cardiology, vascular and interventional medicine and central venous catheters placed centrally or peripherally for short, intermediate, or long term care and their insertion and change kits and supplies. The skin antiseptic Chloraprep and transparent dressing Tegaderm are desired to be used in the kits. The estimated total volume in our Region for this product line is over $212,000 annually. At the request of the Southwest Region Military Treatment Facilities vendors will provide on-site support and in-servicing, educational resources and tools for clinical use of the product, conversion information, prime vendor order numbers, MSDS information, and itemization of the brands, types and packaging information of the products offered by the vendor. C.Instructions to Offerors If you are interested in participating in this standardization initiative, email your (1) Company name and address, (2) POC (Name and Phone Number, Fax Number, E-mail address, your answers to the technical questions/criteria below and product literature to cynthia.ingrao@med.navy.mil no later than August 15, 2007. Vendors that fail to meet the submittal deadline will be disqualified. If your product literature is more than 4MB in size, please mail your product literature to: Cindy Ingrao, RN, MSN Tri-Service Regional Business Office MSMMO - Southwest Region 34800 Bob Wilson Drive, Suite 110 San Diego, CA 92134 Phone: (619) 532-8517 This process will include vendor requirements of electronic responses to technical criteria, no charge samples for clinical evaluation, and submission of electronic best price offers. Due to the potential for email to become lost in transmission due to network security, etc., the vendor is strongly encouraged to confirm with the Region that its quote and literature actually arrived at the Region via email. We strongly recommend that each submitting vendor confirm receipt, allowing enough time for re-submission before the due date, if a problem should occur with the first transmission. D. Evaluation Criteria The Tri-Service Product Review Board (TPRB) is the governing board of the standardization process. This board includes clinicians and logisticians from all of the Military Treatment Facilities within the Southwest Region. They are the decision makers for this initiative. Phase I. Vendors will be required to provide responses to the technical/company criteria. The responses will be reviewed by the TPRB to determine acceptability. After review of the technical/company criteria, those vendors who meet these criteria will be invited to participate in the clinical/performance evaluation. Phase II. The TPRB will request samples from the product group to be clinically evaluated at select Military Treatment Facilities. Vendors are required to ship samples direct to the designated MTFs. Vendors will be given 10 business days to ship samples. Samples must arrive at the MTF by COB, 4PM local time, on the (10th) business day after the notice to ship. Vendors failing to deliver by the deadline will be disqualified from further consideration in the standardization process. The MTFs will evaluate the clinical/performance criteria using a scale from one (1) to five (5) where 1 = Not Acceptable, 2 = Minimally Acceptable, 3 = Neutral, 4 = Acceptable, and 5 = Highly Acceptable. All criteria are weighted equally. The TPRB has set a 3.1 acceptability threshold for all product groups. Clinical/performance results lower than 3.1 will not be considered acceptable and will be disqualified from further consideration in the standardization process. Phase III. After the clinical/performance evaluation are completed and analyzed, all vendors in the clinical evaluation group who met the 3.1 threshold will be asked to submit their best pricing offer based on committed volume of 80% of the total requirements of the MTFs in the Southwest Region. Clinical/performance factors will be weighted more heavily than price. Pricing will be evaluated based on best value to the government and will be based on a committed volume agreement for a two-year period with (3) three possible one-year option periods (not to exceed a total of 5 years). Vendors that fail to offer an incentive discount from DAPA will be disqualified. 1. Technical Criteria Evaluation The TPRB will review the responses from the vendors and determine which vendors meet the criteria and determine acceptability. Acceptability for the purpose of evaluation of the technical criteria means the responses to all questions in this section demonstrate that: 1) the vendor, who will be named the quoter, offering the quote is a distributor or manufacturer of a complete line of the subject medical/surgical consumables; 2) based on the quoter?s responses, the evaluators have reasonable confidence that the product line or products and/or services offered meet the medical standards of care of the community in which such products and/or services are applicable; 3) the quoter has or is obtaining a DAPA for the product line, products and/or services; 4) the quoter has or is obtaining an agreement covering the product line, products and/or services with Cardinal Health, the Prime Vendor for the region; 5) the quoter intends to offer discounts off DAPA for all products included in this standardization initiative (vendors that fail to offer a discount from DAPA will be disqualified); and 6) the quoter?s information provided is factually correct (any misrepresentation of information will disqualify the vendor from further consideration.) 1.Does your company manufacture or distribute monitoring and central venous catheters (including peripheral and midline), their insertion and change kits with Chloraprep skin prep, and supplies or any portion of the above? 2.Are your products available through the Prime Vendor, Cardinal? 3.What is your DAPA Number? 4.Does your company offer volume discounts off DAPA for all products included in this standardization initiative (vendors that fail to offer a discount from DAPA will be disqualified)? 5.Under what brand(s) does your company manufacture or distribute your products? 6.Under what standards are your products manufactured? 7.Are your products FDA approved? 8.Which of your products have safety features to guard against needlestick injuries for the staff? 9.Are your monitoring and central venous catheters, supplies, and kits latex free? 10.If you have products that are not latex free, how is the packaging labeled? 11.What types/specialties of monitoring catheters does your company manufacture? 12.What sizes and configurations are available for your monitoring catheters by type/specialty? 13.What feature(s) does your monitoring catheter have to reduce patient discomfort, reduce catheter breakage, ensure accurate catheter positioning and improve the overall procedure for the patient? 14.Are your monitoring and central venous catheters, supplies, and kits single use and disposable? 15.Are your monitoring and central venous catheters, placement wires and introducers radiopaque and/or fluoroscopically visual? What is the feature that makes it radiopaque and/or fluoroscopically visual? 16.Are your catheters, placement wires or introducers color-coded for size and/or type of material? 17.What types of central venous catheters does your company manufacture? 18.What sizes and configurations are available for your central venous catheters? 19.What feature(s) does your central venous catheter have to reduce patient discomfort, reduce catheter breakage, ensure accurate catheter positioning and improve the overall procedure for the patient? 20.Do your catheters have a feature for visualizing flashback? 21.Do any of your catheters have antimicrobial properties? If so, which catheters and what makes it antimicrobial and what are the rates of efficacy? 22.Do your catheters have safety features to prevent the incidence of needlestick injuries? If so, which catheters and what is that feature? 23.How are your catheters packaged (eaches, boxes, cases)? 24.What type of adhesive is used for the securement components of the kits (self stick, pressure sensitive, etc)? 25.Is your adhesive non-allergenic? 26.Is your adhesive recommended for use with all skin types and populations? 27.Does your adhesive stay in place with various degrees of skin moisture (dry to diaphoretic)? 28.What are the contents of your monitoring and central venous catheter insertion kits? 29.What are the contents of your monitoring and central venous catheter change kits? 30.Do your insertion and change kits have preprinted medication labels? If so, what medications are they preprinted for? 31.Can the contents of your kits be customized? 32.Can the brand of transparent dressing be customized? 33.How are your kits packaged (eaches, boxes, cases)? 34.Do you have any catheters or kits that are non-sterile? 35.Is the use and function of the catheter or kit easily identifiable on the packaging? 36.Does your company have a minimum order requirement for drop-shipment orders? If you do what is the minimum order? What is the drop shipment fee? 37.Are your products available in the lowest unit of measure possible? If they are, what is the lowest unit of measure, and are there additional costs involved? 38.Does your company have a plan to discontinue certain products under this category within 12 months? If yes, list all part numbers that will be discontinued. 39.Does your company have a plan to launch new products under this category within 12 months? 40.Does this kit require in-service training? If so, is this training provided by your company at no charge? 41.What types of educational tools or materials do you have for this product line? 42.What kind of ongoing staff training does your company provide? 43.What are the recommended disposal guidelines for your products? (If products are incinerated for disposal, what are the potential by-products?) 44.If your company is awarded the business for our Region, does your company offer a CME/CEU continuing education program at no cost? 45.Does your company have local representatives to provide assistance at facility locations? 46.What is your company?s return goods policy? 47.What is your company?s proposed implementation plan should your company be awarded the Regional Incentive Agreement? 48.Does your company provide customer service 24/7? 49.Is there any history of backorders and/or recalls for this kit group? If yes, please answer: (a) Dates and duration, (b) Cause, (c) Resolution. 2. Clinical Criteria Evaluation A Clinical Product Team (CPT) comprised of medical professionals from several disciplines will evaluate the products based upon on the following evaluation criteria to determine acceptability. 1.The catheter insertion was easy and smooth using the products in the kit. 2.The contents of the kits and the supplies are made of high quality sturdy material. 3.The kit contains the correct local anesthetic for your facility. 4.The sharps in the kit have a safety feature. 5.The kit contains Chloraprep skin prep. 6.The kit contains Tegaderm for the transparent dressing. 7.All information needed to select the correct catheter or kit is easy to read. 8.The latex content of the kit is clearly identifiable on the package labeling. 9.The contents of the kit are easily identifiable on the packaging. 10.The kit contained all the necessary items needed for bedside insertion and/or dressing change.
 
Record
SN01353664-W 20070728/070726222530 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.